N-Oleoyl-L-Serine

CAS No. 107743-37-3

N-Oleoyl-L-Serine( —— )

Catalog No. M34817 CAS No. 107743-37-3

N-Oleoyl-L-Serine (N-Oleoylserine) is an endogenous long-chain fatty acid amide that is a lipid modulator of bone remodeling and stimulates osteoclast apoptosis which can be used to study osteoporosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 73 Get Quote
5MG 185 Get Quote
10MG 328 Get Quote
25MG 536 Get Quote
50MG 766 Get Quote
100MG 1035 Get Quote
200MG 1395 Get Quote
500MG 2061 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    N-Oleoyl-L-Serine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Oleoyl-L-Serine (N-Oleoylserine) is an endogenous long-chain fatty acid amide that is a lipid modulator of bone remodeling and stimulates osteoclast apoptosis which can be used to study osteoporosis.
  • Description
    N-Oleoyl-L-Serine is an endogenous amide of long-chain fatty acids with ethanolamine (N-acyl amides). N-Oleoyl-L-Serine is a lipid regulator of bone remodeling and stimulates osteoclast apoptosis. N-Oleoyl-L-Serine can be used for antiosteoporotic drug discovery development.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    107743-37-3
  • Formula Weight
    369.54
  • Molecular Formula
    C21H39NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N([C@H](C(O)=O)CO)C(CCCCCCC/C=C\CCCCCCCC)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Reem Smoum, et al. Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17710-5.?
molnova catalog
related products
  • JHU395

    JHU395 is an orally-bioavailable prodrug of a lipophilic glutamine antagonist (GA), 6-diazo-5-oxo-L-norleucine (DON).

  • SKI-178

    SKI-178 is a sphingosine kinase 1 (SphK1) inhibitor with IC50 of 0.1-1.8 μM.?

  • DT2216

    DT2216 inhibits various Bcl-XL-dependent leukemias and cancer cells, but is significantly less toxic to platelets.DT2216 is a selective B-cell lymphoma, extremely large (BCL-XL), proteolytic targeting chimera (PROTAC).